The Implied Analyst 12-Month Target For JHML
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 13 2025
0mins
Should l Buy COTY?
Source: NASDAQ.COM
ETF Analysis: The John Hancock Multifactor Large Cap ETF (JHML) has an implied analyst target price of $79.86 per unit, indicating a potential upside of 15.56% from its current trading price of $69.11.
Stock Performance Insights: Notable underlying holdings such as Coty, CAVA Group, and GitLab show significant upside potential based on analysts' target prices, raising questions about the validity and optimism of these targets in light of recent market developments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.350
Low
2.50
Averages
4.30
High
10.00
Current: 2.350
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Multiple Companies Face Class Action Lawsuits
- Lufax Class Action: Lufax Holding Ltd. is facing allegations for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, which undermines investor confidence due to misleading positive statements about the company's prospects.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. is accused of not disclosing manufacturing issues and clinical trial risks from May 20, 2024, to January 9, 2026, potentially overstating the likelihood of FDA approval for its product, which could significantly impact the company's financial condition.
- Coty Legal Issues: Coty Inc. is under scrutiny for failing to reveal underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, leading to misleading positive statements about its business operations and prospects, which may affect investor trust.
- Legal Consultation Reminder: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to reach out for legal rights discussions, emphasizing the firm's commitment to protecting investor interests.
See More
Coty Shareholder Class Action Notice
- Class Action Timeline: Shareholders of Coty Inc. who purchased common stock between November 5, 2025, and February 4, 2026, should be aware of the May 22, 2026, lead plaintiff deadline to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Coty made false and/or misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, particularly the underperformance in the Consumer Beauty segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, highlighting its strong reputation in the field.
- Participation Instructions: Investors can contact the Rosen Law Firm via the provided website or toll-free number to learn how to join the class action without any upfront costs, ensuring their rights are protected.
See More
Coty Faces Securities Class Action Lawsuit
- Lawsuit Deadline: Coty Inc. reminds investors that May 22, 2026, is the deadline to apply for lead plaintiff status in a pending federal securities class action, emphasizing the urgency for investors to act swiftly to protect their rights.
- Disappointing Performance: In its Q2 fiscal 2026 earnings report, Coty revealed underperformance in its Consumer Beauty segment, leading to the withdrawal of its EBITDA guidance, reflecting significant pressure and uncertainty in the market that could impact investor confidence moving forward.
- Stock Price Decline: Following the disappointing earnings announcement, Coty's stock price plummeted approximately 15.6% on February 5, 2026, from $3.15 to $2.66 per share, indicating a pessimistic market sentiment regarding the company's growth prospects.
- Market Underperformance: Coty acknowledged stagnation in its Prestige fragrance sales and significant underperformance in the Consumer Beauty market compared to the U.S. mass cosmetics sector, highlighting major challenges in strategic execution and market adaptability.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased stock between November 5, 2025, and February 4, 2026, stemming from serious operational issues and the abrupt departure of CEO Sue Y. Nabi, which caused the stock price to drop over 8% on the announcement day.
- Financial Misrepresentation: The lawsuit alleges that Coty made false statements in its November 5, 2025, earnings report, failing to disclose underperformance in the Consumer Beauty market and margin compression due to increased marketing investments, leading to significant losses for investors in subsequent reports.
- Performance Decline: The Q2 2026 earnings report revealed a staggering over 70% drop in operating income for the Consumer Beauty segment and an 18% decline for Prestige, prompting the company to withdraw its FY 2026 EBITDA and free cash flow guidance, further unsettling the market.
- Investigation Progress: Hagens Berman is investigating whether Coty intentionally misled investors and is examining the circumstances surrounding CEO Nabi's sudden departure, urging affected investors to submit information to assist in the investigation.
See More
Coty Investors Reminded of Class Action Deadline
- Disappointing Earnings: Coty's Q2 fiscal 2026 results revealed a 6% decline in net revenue, a 200 basis point drop in gross margins, and a 19% decrease in adjusted operating income, indicating significant challenges in the consumer beauty segment that have undermined investor confidence.
- Management Changes: Interim CEO Markus Strobel acknowledged the company's failure to meet expectations and emphasized the need for investments in operational effectiveness and marketing support to reverse the current performance decline, indicating a strategic pivot for the company.
- Stock Price Plunge: Following the earnings report, Coty's stock fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, directly impacting investor asset values and reflecting a pessimistic outlook on the company's future.
- Class Action Initiation: Investors are reminded to file lead plaintiff motions by May 22, 2026, alleging that Coty failed to disclose the underperformance of its consumer beauty segment and other adverse information during the class period, potentially leading to further financial losses for investors.
See More
BellRing Brands Shareholder Investigation Launched
- Shareholder Investigation Launched: Grabar Law Office is investigating BellRing Brands, Inc. (NYSE:BRBR) for potential breaches of fiduciary duties by its officers, allowing shareholders who purchased before October 1, 2024, to seek corporate reforms and fund recovery.
- False Statements Allegations: A recently filed federal securities fraud class action alleges that BellRing's executives failed to disclose that customers accumulated excess inventory due to prior product shortages, leading to materially misleading statements about the company's business prospects.
- Coty Investigation: Grabar Law Office is also investigating Coty Inc. (NYSE:COTY) for potential fiduciary breaches, enabling shareholders who purchased before November 5, 2025, to seek corporate reforms and fund recovery.
- e.l.f. Beauty Lawsuit: The securities fraud class action against e.l.f. Beauty (NYSE:ELF) has survived a motion to dismiss, alleging that executives concealed declining demand and excess inventory, allowing shareholders to seek corporate reforms and fund recovery.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Class Action: Lufax Holding Ltd. is facing allegations for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, which undermines investor confidence due to misleading positive statements about the company's prospects.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. is accused of not disclosing manufacturing issues and clinical trial risks from May 20, 2024, to January 9, 2026, potentially overstating the likelihood of FDA approval for its product, which could significantly impact the company's financial condition.
- Coty Legal Issues: Coty Inc. is under scrutiny for failing to reveal underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, leading to misleading positive statements about its business operations and prospects, which may affect investor trust.
- Legal Consultation Reminder: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to reach out for legal rights discussions, emphasizing the firm's commitment to protecting investor interests.
See More
Coty Shareholder Class Action Notice
- Class Action Timeline: Shareholders of Coty Inc. who purchased common stock between November 5, 2025, and February 4, 2026, should be aware of the May 22, 2026, lead plaintiff deadline to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Coty made false and/or misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, particularly the underperformance in the Consumer Beauty segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, highlighting its strong reputation in the field.
- Participation Instructions: Investors can contact the Rosen Law Firm via the provided website or toll-free number to learn how to join the class action without any upfront costs, ensuring their rights are protected.
See More
Coty Faces Securities Class Action Lawsuit
- Lawsuit Deadline: Coty Inc. reminds investors that May 22, 2026, is the deadline to apply for lead plaintiff status in a pending federal securities class action, emphasizing the urgency for investors to act swiftly to protect their rights.
- Disappointing Performance: In its Q2 fiscal 2026 earnings report, Coty revealed underperformance in its Consumer Beauty segment, leading to the withdrawal of its EBITDA guidance, reflecting significant pressure and uncertainty in the market that could impact investor confidence moving forward.
- Stock Price Decline: Following the disappointing earnings announcement, Coty's stock price plummeted approximately 15.6% on February 5, 2026, from $3.15 to $2.66 per share, indicating a pessimistic market sentiment regarding the company's growth prospects.
- Market Underperformance: Coty acknowledged stagnation in its Prestige fragrance sales and significant underperformance in the Consumer Beauty market compared to the U.S. mass cosmetics sector, highlighting major challenges in strategic execution and market adaptability.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased stock between November 5, 2025, and February 4, 2026, stemming from serious operational issues and the abrupt departure of CEO Sue Y. Nabi, which caused the stock price to drop over 8% on the announcement day.
- Financial Misrepresentation: The lawsuit alleges that Coty made false statements in its November 5, 2025, earnings report, failing to disclose underperformance in the Consumer Beauty market and margin compression due to increased marketing investments, leading to significant losses for investors in subsequent reports.
- Performance Decline: The Q2 2026 earnings report revealed a staggering over 70% drop in operating income for the Consumer Beauty segment and an 18% decline for Prestige, prompting the company to withdraw its FY 2026 EBITDA and free cash flow guidance, further unsettling the market.
- Investigation Progress: Hagens Berman is investigating whether Coty intentionally misled investors and is examining the circumstances surrounding CEO Nabi's sudden departure, urging affected investors to submit information to assist in the investigation.
See More
Coty Investors Reminded of Class Action Deadline
- Disappointing Earnings: Coty's Q2 fiscal 2026 results revealed a 6% decline in net revenue, a 200 basis point drop in gross margins, and a 19% decrease in adjusted operating income, indicating significant challenges in the consumer beauty segment that have undermined investor confidence.
- Management Changes: Interim CEO Markus Strobel acknowledged the company's failure to meet expectations and emphasized the need for investments in operational effectiveness and marketing support to reverse the current performance decline, indicating a strategic pivot for the company.
- Stock Price Plunge: Following the earnings report, Coty's stock fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, directly impacting investor asset values and reflecting a pessimistic outlook on the company's future.
- Class Action Initiation: Investors are reminded to file lead plaintiff motions by May 22, 2026, alleging that Coty failed to disclose the underperformance of its consumer beauty segment and other adverse information during the class period, potentially leading to further financial losses for investors.
See More
BellRing Brands Shareholder Investigation Launched
- Shareholder Investigation Launched: Grabar Law Office is investigating BellRing Brands, Inc. (NYSE:BRBR) for potential breaches of fiduciary duties by its officers, allowing shareholders who purchased before October 1, 2024, to seek corporate reforms and fund recovery.
- False Statements Allegations: A recently filed federal securities fraud class action alleges that BellRing's executives failed to disclose that customers accumulated excess inventory due to prior product shortages, leading to materially misleading statements about the company's business prospects.
- Coty Investigation: Grabar Law Office is also investigating Coty Inc. (NYSE:COTY) for potential fiduciary breaches, enabling shareholders who purchased before November 5, 2025, to seek corporate reforms and fund recovery.
- e.l.f. Beauty Lawsuit: The securities fraud class action against e.l.f. Beauty (NYSE:ELF) has survived a motion to dismiss, alleging that executives concealed declining demand and excess inventory, allowing shareholders to seek corporate reforms and fund recovery.
See More
